why choose us

First received: August 14, 2023

Clinical Trial: Duration and Efficacy of Azstarys on Adult ADHD Symptoms and Executive Function in Early Evening

Study Status: Completed

Recruit Status: RECRUITING

Condition: Adult Attention Deficit Hyperactivity Disorder

Study Type: INTERVENTIONAL


Official Title: An Open-Label Treatment, Investigator-Initiated Study, on the Duration and Efficacy of Azstarys (Serdexmethylphenidate and Dexmethylphenidate) on Adult ADHD Symptoms and Executive Function in Early Ev

Brief Summary: This is a single-site study.One purpose of this trial is to extend the safety and efficacy evidence basis for Azstarys in adults with ADHD.This open-label, treatment study will examine the efficacy of Azstarys on ADHD symptoms using the AISRS 18-item total score on the AISRS-expanded; the Adult ADHD Investigator Symptom Rating Scale.The investigators will also examine Executive Function later in the day (early evening, about 12 hours after first morning dosing).

Read more